• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[视网膜静脉阻塞患者的血栓形成倾向及全身危险因素]

[Thrombophilic and systemic risk factors in patients with retinal vein occlusion].

作者信息

Kuhli-Hattenbach C, Miesbach W, Scharrer I, Hattenbach L-O

机构信息

Klinik für Augenheilkunde, Universitätsklinikum Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Deutschland.

出版信息

Ophthalmologe. 2011 Feb;108(2):104-10. doi: 10.1007/s00347-010-2289-2.

DOI:10.1007/s00347-010-2289-2
PMID:21287178
Abstract

Over the past years there has been a dramatic increase in the number of identifiable causes of thrombophilia. However, as retinal vein occlusions (RVO) have a strong pathogenic correlation with the presence of hypertension or arteriosclerosis and the average age of affected patients is usually within the sixth or seventh decade of life, thrombophilia screening of RVO patients poses a particularly difficult diagnostic challenge. It is clear that to use medical resources appropriately and improve the level of interdisciplinary patient care in RVO, subgroup analysis is required. Just recently, some studies have demonstrated the significant role of coagulation disorders in specific subgroups of RVO patients and have provided recommendations for clinical practice. These results indicate that thrombophilic risk factors are significantly more prevalent among patients equal or less than 45 years of age at the time of RVO or a previous thromboembolic event, among patients with a remarkable family history of thromboembolism prior to the age of 45 years, or among patients without cardiovascular risk factors. According to these data, thrombophilia screening should be considered in these selected subgroups.

摘要

在过去几年中,可识别的血栓形成倾向病因数量急剧增加。然而,由于视网膜静脉阻塞(RVO)与高血压或动脉硬化的存在有很强的致病相关性,且受影响患者的平均年龄通常在六七十岁,对RVO患者进行血栓形成倾向筛查提出了特别困难的诊断挑战。显然,为了合理利用医疗资源并提高RVO患者跨学科护理水平,需要进行亚组分析。最近,一些研究已经证明了凝血障碍在RVO患者特定亚组中的重要作用,并为临床实践提供了建议。这些结果表明,在发生RVO或既往血栓栓塞事件时年龄等于或小于45岁的患者中、在45岁之前有明显血栓栓塞家族史的患者中或在没有心血管危险因素的患者中,血栓形成倾向危险因素明显更为普遍。根据这些数据,应在这些选定的亚组中考虑进行血栓形成倾向筛查。

相似文献

1
[Thrombophilic and systemic risk factors in patients with retinal vein occlusion].[视网膜静脉阻塞患者的血栓形成倾向及全身危险因素]
Ophthalmologe. 2011 Feb;108(2):104-10. doi: 10.1007/s00347-010-2289-2.
2
Coagulation disorders and the risk of retinal vein occlusion.凝血障碍与视网膜静脉阻塞的风险。
Thromb Haemost. 2010 Feb;103(2):299-305. doi: 10.1160/TH09-05-0331. Epub 2009 Nov 13.
3
[Selective thrombophilia screening of young patients with retinal vein occlusion].[对年轻视网膜静脉阻塞患者进行选择性血栓形成倾向筛查]
Klin Monbl Augenheilkd. 2009 Sep;226(9):768-73. doi: 10.1055/s-0028-1109195. Epub 2009 Apr 27.
4
Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion.脂蛋白(a)水平升高是视网膜静脉阻塞的独立危险因素。
Acta Ophthalmol. 2017 Mar;95(2):140-145. doi: 10.1111/aos.13228. Epub 2016 Aug 22.
5
Retinal vein occlusion: evaluation of "classic" and "emerging" risk factors and treatment.视网膜静脉阻塞:“经典”和“新兴”危险因素的评估与治疗。
J Thromb Thrombolysis. 2010 May;29(4):459-64. doi: 10.1007/s11239-009-0384-5.
6
Thrombophilic and cardiovascular risk factors for retinal vein occlusion.视网膜静脉阻塞的血栓形成和心血管危险因素。
Eur J Intern Med. 2017 Oct;44:44-48. doi: 10.1016/j.ejim.2017.06.022. Epub 2017 Jul 3.
7
Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.土耳其人群中视网膜静脉阻塞、同型半胱氨酸与血栓形成倾向突变的关联:一项病例对照研究。
Ophthalmic Genet. 2017 Jul-Aug;38(4):352-356. doi: 10.1080/13816810.2016.1235716. Epub 2017 Jan 13.
8
[Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].65岁以下视网膜静脉阻塞患者的多种血栓形成风险标志物
Ophthalmologe. 2017 Dec;114(12):1149-1154. doi: 10.1007/s00347-017-0456-4.
9
The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.血栓形成倾向在无系统性危险因素的视网膜静脉阻塞患者中的作用。
Can J Ophthalmol. 2010 Apr;45(2):171-5. doi: 10.3129/i09-273.
10
Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.凝血酶原多态性A19911G、凝血因子V HR2单倍型A4070G、纤溶酶原激活物抑制剂-1多态性4G/5G与视网膜静脉阻塞风险
Ophthalmic Genet. 2017 Sep-Oct;38(5):413-417. doi: 10.1080/13816810.2016.1244694. Epub 2017 Jan 13.

引用本文的文献

1
[Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].65岁以下视网膜静脉阻塞患者的多种血栓形成风险标志物
Ophthalmologe. 2017 Dec;114(12):1149-1154. doi: 10.1007/s00347-017-0456-4.
2
[Bilateral simultaneous central retinal vein occlusion in protein S deficiency].[蛋白S缺乏症所致双侧同时性视网膜中央静脉阻塞]
Ophthalmologe. 2015 Nov;112(11):929-31. doi: 10.1007/s00347-015-3234-1.
3
[Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].

本文引用的文献

1
The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.血栓形成倾向在无系统性危险因素的视网膜静脉阻塞患者中的作用。
Can J Ophthalmol. 2010 Apr;45(2):171-5. doi: 10.3129/i09-273.
2
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.抗血栓和纤维蛋白溶解药物治疗视网膜静脉阻塞:系统评价和行动呼吁。
Thromb Haemost. 2010 Feb;103(2):271-6. doi: 10.1160/TH09-09-0626. Epub 2009 Dec 1.
3
Coagulation disorders and the risk of retinal vein occlusion.凝血障碍与视网膜静脉阻塞的风险。
[根据黄斑水肿持续时间对视网膜分支静脉阻塞患者进行玻璃体腔内治疗]
Ophthalmologe. 2013 Oct;110(10):966-74. doi: 10.1007/s00347-012-2723-8.
Thromb Haemost. 2010 Feb;103(2):299-305. doi: 10.1160/TH09-05-0331. Epub 2009 Nov 13.
4
The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish sample.视网膜静脉阻塞患者中蛋白C、蛋白S和抗凝血酶III的缺乏:土耳其样本。
Clin Lab Haematol. 2006 Dec;28(6):391-2. doi: 10.1111/j.1365-2257.2006.00834.x.
5
Retinal vein occlusion associated with antithrombin deficiency secondary to a novel G9840C missense mutation.与一种新型G9840C错义突变继发的抗凝血酶缺乏相关的视网膜静脉阻塞。
Arch Ophthalmol. 2006 Aug;124(8):1165-9. doi: 10.1001/archopht.124.8.1165.
6
Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.60岁以下视网膜静脉阻塞患者中因子V莱顿突变的患病率增加。
Thromb Haemost. 2005 Jul;94(1):101-6. doi: 10.1160/TH04-10-0659.
7
Defective thrombus formation in mice lacking coagulation factor XII.缺乏凝血因子XII的小鼠中血栓形成缺陷。
J Exp Med. 2005 Jul 18;202(2):271-81. doi: 10.1084/jem.20050664. Epub 2005 Jul 11.
8
Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.家族性易栓症患者首次静脉血栓形成后的复发率。
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1992-7. doi: 10.1161/01.ATV.0000174806.76629.7b. Epub 2005 Jun 23.
9
Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.凝血因子 XII 缺乏症:视网膜静脉阻塞的一种血栓形成风险因素。
Am J Ophthalmol. 2004 Mar;137(3):459-64. doi: 10.1016/j.ajo.2003.10.024.
10
Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.与视网膜中央静脉阻塞和半侧视网膜中央静脉阻塞相关的眼压异常。
Ophthalmology. 2004 Jan;111(1):133-41. doi: 10.1016/j.ophtha.2003.03.002.